超声造影肝脏影像报告与数据系统在甲胎蛋白阴性肝细胞癌高危患者中的应用

郑丽丽; 任新平; 詹维伟; 冯梅晶; 李军建

您当前的位置：

首页 >

文章列表页 >

超声造影肝脏影像报告与数据系统在甲胎蛋白阴性肝细胞癌高危患者中的应用

临床研究 | 更新时间：2023-10-09

- 超声造影肝脏影像报告与数据系统在甲胎蛋白阴性肝细胞癌高危患者中的应用
- Application of contrast-enhanced ultrasound liver imaging reporting and data system in high-risk patients with alpha-fetoprotein- negative hepatocellular carcinoma
- 临床超声医学杂志 2022年24卷第11期
- 作者机构：
  
  江苏省无锡市新吴区新瑞医院上海交通大学医学院附属瑞金医院无锡分院超声科
- 作者简介：
- 基金信息：
- DOI：
  中图分类号：
- 纸质出版日期：2022，
  
  网络出版日期：2022-11-25，
扫描看全文
郑丽丽, 任新平, 詹维伟, 等. 超声造影肝脏影像报告与数据系统在甲胎蛋白阴性肝细胞癌高危患者中的应用[J]. 临床超声医学杂志, 2022,24(11).

Application of contrast-enhanced ultrasound liver imaging reporting and data system in high-risk patients with alpha-fetoprotein- negative hepatocellular carcinoma[J]. Journal of Clinical Ultrasound in Medicine, 2022,24(11).
郑丽丽, 任新平, 詹维伟, 等. 超声造影肝脏影像报告与数据系统在甲胎蛋白阴性肝细胞癌高危患者中的应用[J]. 临床超声医学杂志, 2022,24(11). DOI：

Application of contrast-enhanced ultrasound liver imaging reporting and data system in high-risk patients with alpha-fetoprotein- negative hepatocellular carcinoma[J]. Journal of Clinical Ultrasound in Medicine, 2022,24(11). DOI：

摘要

目的研究超声造影肝脏影像报告与数据系统2017版（CEUS LI-RADS v2017）在甲胎蛋白（AFP）阴性的肝细胞癌（HCC）高危患者肝局灶性病变中的应用价值。方法回顾性分析2018年1月至2021年10月在我院行CEUS检查的AFP阴性HCC高危患者108例（134个结节），采用CEUS LI-RADS v2017对结节进行分类，以组织病理学结果或增强影像学检查和随访结果为金标准，计算CEUS LI-RADS对AFP阴性患者HCC和肝内其他恶性肿瘤（OM）的诊断敏感性、特异性、阳性预测值、阴性预测值、准确率、受试者工作特征曲线下面积（AUC）。结果 AFP阴性HCC较OM小（P＜0.001）。CEUS LR-5类、LR-4类、LR-3类对AFP阴性HCC的阳性预测值分别为88.37%、47.06%、12.9%。LR-5类诊断AFP阴性HCC的敏感性、特异性、准确率和AUC分别为73.07%、 93.90%、85.82%和0.87。LR-M类诊断OM的敏感性、特异性、阳性预测值、阴性预测值、准确率和AUC分别为90.91%、97.32%、86.96%、98.20%、96.27%和0.94。结论AFP阴性HCC较OM小，CEUS LI-RADS v2017对AFP阴性HCC诊断特异性较高而敏感性较低，对OM有较好的诊断价值。

Abstract

Objective To investigate the application of contrast-enhanced ultrasound liver imaging reporting and data system version 2017 (CEUS LI-RADS v2017)for focal liver lesions in high-risk patients with alpha-fetoprotein(AFP)-negative. Methods From January 2018 to October 2021

134 focal liver lesions in 108 high-risk patients with AFP-negative who underwent contrast-enhanced ultrasound were retrospectively analyzed. Nodules were categorized according to the CEUS LI-RADS v2017.The reference standard was histopathology or contrast-enhanced imaging and follow-up.The sensitivity

specificity

positive predictive value

negative predictive value

accuracy and area under the curve (AUC)of CEUS LI-RADS for HCC and other malignant tumors (OM) in AFP-negative patients were calculated. Results AFP-negative HCC was smaller than OM (P< 0.001). The positive predictive values of AFP-negative HCC in LR-5

LR-4

and LR-3 were88.37%

47.06% and 12.9%

respectively.The sensitivity

specificity

accuracy and AUC of LR-5 for AFP-negative HCC were 73.07%

93.90%

85.82% and 0.87

respectively.The sensitivity

specificity

positive predictive value

negative predictive value

accuracy and AUC of LR-M for OM were 90.91%

97.32%

86.96%

98.20%

96.27% and 0.94

respectively. Conclusions AFP-negative HCC was smaller than OM. CEUS Li-RADS v2017 shows high specificity and low sensitivity for AFP-negative HCC and good diagnostic efficiency for OM.

关键词

甲胎蛋白肝细胞癌超声检查造影剂肝脏影像报告与数据系统

Keywords

alpha-fetoproteinHepatocellular carcinomaUltrasonographyContrast agentLiver imaging reporting and data system

references

查看原文

浏览量

194

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

超声造影延迟相廓清的肝炎性病灶与肝细胞癌的鉴别与分析

肝细胞癌患者超声造影特征与其肿瘤标志物表达的临床研究